Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Psychopharmacology

• Publication date

  2009-05-26

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-009-1550-3PMID 19468717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci

  2023cited by this paper
• Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.

  2010influential reference
• The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.

  2008cited by this paper
• An interaction between the norepinephrine transporter and monoamine oxidase A polymorphisms, and novelty-seeking personality traits in Korean females.

  2008cited by this paper
• Renin-angiotensin-system gene polymorphisms and depression.

  2007cited by this paper
• No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population.

  2007influential reference
• Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients

  2007cited by this paper
• Mapping regulatory variants for the serotonin transporter gene based on allelic expression imbalance

  2007cited by this paper
• Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample.

  2007cited by this paper
• Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression.

  2006cited by this paper
• The 5‐HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: The PREDICT‐gene study

  2006cited by this paper
• Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.

  2006influential reference
• SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci

  2005cited by this paper
• Reward dependence is related to norepinephrine transporter T-182C gene polymorphism in a Korean population

  2005cited by this paper
• Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs

  2005cited by this paper
• SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression

  2004influential reference
• Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression.

  2004influential reference
• Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.

  2004influential reference
• Positive Association between T-182C Polymorphism in the Norepinephrine Transporter Gene and Susceptibility to Major Depressive Disorder in a Japanese Population

  2004cited by this paper
• Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

  2004cited by this paper
• Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.

  2004influential reference
• Association between Norepinephrine Transporter Gene Polymorphism and Major Depression

  2004cited by this paper
• Racial/ethnic differences in rates of depression among preretirement adults.

  2003cited by this paper
• Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene

  2003influential reference
• A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior

  2003cited by this paper
• 5-HTTLPR Polymorphism of the Serotonin Transporter Gene Predicts Non-Remission in Major Depression Patients Treated With Citalopram in a 12-Weeks Follow Up Study

  2003cited by this paper
• A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders

  2003cited by this paper
• Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond.

  2003cited by this paper
• Association Study of Serotonin Transporter Gene VNTR Polymorphism and Mood Disorders, Onset Age and Suicide Attempts in a Chinese Sample

  2003cited by this paper
• Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

  2002cited by this paper
• A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine.

  2002cited by this paper
• Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

  2002cited by this paper
• Identification of a Naturally Occurring Polymorphism in the Promoter Region of the Norepinephrine Transporter and Analysis in Major Depression

  2002influential reference
• Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment.

  2002cited by this paper
• Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression.

  2001cited by this paper
• Mental Health: New Understanding, New Hope

  2001influential reference
• From the World Health Organization. Mental health: new understanding, new hope.

  2001influential reference
• Serotonin 1A Receptors, Serotonin Transporter Binding and Serotonin Transporter mRNA Expression in the Brainstem of Depressed Suicide Victims

  2001cited by this paper
• Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders.

  2000cited by this paper
• Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices.

  2000cited by this paper
• The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants

  2000cited by this paper
• Serotonin transporter gene polymorphism and antidepressant response

  2000influential reference
• A Previously Undescribed Intron and Extensive 5′ Upstream Sequence, but Not Phox2a-mediated Transactivation, Are Necessary for High Level Cell Type-specific Expression of the Human Norepinephrine Transporter Gene*

  1999cited by this paper
• A population-based twin study of lifetime major depression in men and women.

  1999cited by this paper
• Bipolar disorder and the serotonin transporter gene: a family-based association study

  1999cited by this paper
• Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers.

  1998cited by this paper
• Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression

  1997cited by this paper
• Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder

  1996cited by this paper
• Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression.

  1988cited by this paper
• THE WORLD HEALTH ORGANIZATION

  1954cited by this paper

• Molecular pathways linking the serotonin transporters (SERT) to depressive disorder: from mechanisms to treatments.

  2025cites this paper
• Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers

  2023cites this paper
• The Role of Variability in Monoamine Transporter Genes in Sports Physiology

  2023cites this paper
• The Role of Variability in Monoamine Transporter Genes in Sport Physiology

  2023cites this paper
• Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach.

  2023cites this paper
• Genetics of antidepressant response and treatment-resistant depression.

  2023cites this paper
• Region-specific microRNA alterations in marmosets carrying SLC6A4 polymorphisms are associated with anxiety-like behavior

  2022cites this paper
• FARMAKOGENETİĞİN ANTİDEPRESANLARIN KLİNİK KULLANIMI ÜZERİNE ETKİSİ

  2022cites this paper
• Association between T-182C polymorphism of the norepinephrine transporter SLC6A2(NET) gene and major depressive disorder in Iraqi patients

  2022cites this paper
• The Biological Mechanisms Underlying Major Depressive Disorder

  2021cites this paper
• Personalized Pharmacotherapy: A Historical Perspective on the Pharmacogenomics of Depression

  2021cites this paper
• DRDInfluence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.

  2020cites this paper
• Pharmacogenetic association of bi- and triallelic polymorphisms of SLC6A4 with antidepressant response in major depressive disorder.

  2020cites this paper
• The T-182C Polymorphism Enhances Promoter Activity of the Norepinephrine Transporter Gene, but may not be Associated with Antidepressant Response

  2020cites this paper
• Association between genetic polymorphism and antidepressants in major depression: a network meta-analysis.

  2020cites this paper
• The association between polymorphism of norepinephrine transporter G1287A and major depressive disorder, antidepressant response: a meta-analysis

  2020cites this paper
• Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk

  2019cites this paper
• Associations of the serotonin transporter promoter polymorphism (5‐HTTLPR) with bipolar disorder and treatment response: A systematic review and meta‐analysis

  2019cites this paper
• Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.

  2019cites this paper
• Blood-based biomarkers predicting response to antidepressants

  2018cites this paper
• Lafoensia pacari A. St.-Hil.: Wound healing activity and mechanism of action of standardized hydroethanolic leaves extract.

  2018cites this paper
• Meta-analysis on the Association Between Norepinephrine Transporter Gene rs2242446, rs5569 Polymorphisms and Risk of Major Depressive Disorder.

  2018cites this paper
• Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry

  2017cites this paper
• Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years

  2017cites this paper
• Personalized Therapeutics: First Take Home Messages

  2017cites this paper
• Changes in PPARδ expression in a rat model of stress‐induced depression

  2017cites this paper
• Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children

  2017cites this paper
• NTRK2 gene-environment interaction for predicting antidepressant response in patients with major depressive disorder

  2017cites this paper
• Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.

  2015cites this paper
• Association study between 5-HT2A and NET gene polymorphisms and recurrent major depression disorder in Chinese Han population.

  2015cites this paper
• Association of serotonin transporter (SLC6A4) & receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study

  2015cites this paper
• SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population.

  2015cites this paper
• Analysis of Association between Norepinephrine Transporter Gene Polymorphisms and Personality Traits of NEO-FFI in a Japanese Population

  2015cites this paper
• Effects of Remission and Genetic Variation on Brain Structure in Treatment-Resistant Major Depressive Disorder: A Prospective, Longitudinal Imaging Study

  2015cites this paper
• Современное состояние и перспективы развития фармакогенетических исследований в области терапии депрессии

  2015cites this paper
• [Current state and potential of pharmacogenetic studies in the treatment of depression].

  2015cites this paper
• Are there meaningful biomarkers of treatment response for depression?

  2014cites this paper
• Drugs, genes and the blues: pharmacogenetics of the antidepressant response from mouse to man.

  2014cites this paper
• Polymorphisms in Serotonergic Pathways Influence the Outcome of Antidepressant Therapy in Psychiatric Inpatients

  2014cites this paper
• From Pharmacogenetics to Pharmacogenomics: The Way toward the Personalization of Antidepressant Treatment

  2014cites this paper
• The relevance of checking population allele frequencies and Hardy-Weinberg Equilibrium in genetic association studies: the case of SLC6A4 5-HTTLPR polymorphism in a Chinese Han Irritable Bowel Syndrome association study.

  2014cites this paper
• Pharmakogenetische Untersuchungen psychiatrischer Patienten: Bestimmung ausgewählter genetischer Varianten in pharmakokinetischen und pharmakodynamischen Strukturen und deren Bedeutung für die Psychopharmakotherapie

  2014cites this paper
• A Neurobiological Hypothesis of Treatment-Resistant Depression – Mechanisms for Selective Serotonin Reuptake Inhibitor Non-Efficacy

  2014cites this paper
• Understanding the pharmacogenetics of selective serotonin reuptake inhibitors

  2014cites this paper
• Antidepressant treatment response is modulated by genetic and environmental factors and their interactions

  2014influential citation
• The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder

  2014cites this paper
• Association between norepinephrine transporter gene (SLC6A2) polymorphisms and suicide in patients with major depressive disorder.

  2014cites this paper
• Pharmacogenetics of Antidepressant Drugs: An Update

  2014cites this paper
• Pharmacogenetics in major depression: a comprehensive meta-analysis.

  2013influential citation
• Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression

  2013cites this paper
• Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy

  2013cites this paper
• Psychomotor depressive symptoms may differentially respond to venlafaxine

  2013cites this paper
• Antidepressive effect of paroxetine in a rat model: upregulating expression of serotonin and norepinephrine transporter

  2013cites this paper
• Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis.

  2013cites this paper
• Personalized medicine in psychiatry: problems and promises

  2013influential citation
• Pharmacogenetics of antidepressant drugs: An update after almost 20 years of research

  2013cites this paper
• Behavioural genetics of the serotonin transporter.

  2012cites this paper
• The norepinephrine transporter gene is associated with the retardation symptoms of major depressive disorder in the Han Chinese population

  2012cites this paper
• Genetic factors modulating the response to stimulant drugs in humans.

  2012cites this paper
• Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries.

  2012cites this paper
• Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy.

  2012influential citation
• AVPR1A and SLC6A4 Polymorphisms in Choral Singers and Non-Musicians: A Gene Association Study

  2012cites this paper
• Genetics and personalized medicine in antidepressant treatment.

  2012cites this paper
• The genetics of selective serotonin reuptake inhibitors.

  2012influential citation
• Pharmacogenetics of antidepressants and mood stabilizers.

  2012cites this paper
• Do we need pharmacogenetics to personalize antidepressant therapy?

  2012cites this paper
• Genetics in Psychiatry - up-to-date review 2011.

  2011cites this paper
• Pharmacogenetics of antidepressant response.

  2011cites this paper
• A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders

  2011cites this paper
• Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome

  2011cites this paper
• Serotonin Transporter Gene Polymorphism in Chinese Patients With Poststroke Depression: A Case-Control Study

  2011cites this paper
• Pharmacogenomics of antidepressant treatment effects

  2011cites this paper
• Monoamine transporters: vulnerable and vital doorkeepers.

  2011cites this paper
• Pharmacogenetics of Antidepressants

  2010influential citation
• Serotonin Transporter Gene Polymorphism Associated with Short-Term Treatment Response to Venlafaxine

  2010cites this paper
• Current awareness in human psychopharmacology

  2010cites this paper